Literature DB >> 26428618

In vitro cardiac tissue models: Current status and future prospects.

Anurag Mathur1, Zhen Ma1, Peter Loskill1, Shaheen Jeeawoody2, Kevin E Healy3.   

Abstract

Cardiovascular disease is the leading cause of death worldwide. Achieving the next phase of potential treatment strategies and better prognostic tools will require a concerted effort from interdisciplinary fields. Biomaterials-based cardiac tissue models are revolutionizing the area of preclinical research and translational applications. The goal of in vitro cardiac tissue modeling is to create physiological functional models of the human myocardium, which is a difficult task due to the complex structure and function of the human heart. This review describes the advances made in area of in vitro cardiac models using biomaterials and bioinspired platforms. The field has progressed extensively in the past decade, and we envision its applications in the areas of drug screening, disease modeling, and precision medicine.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomaterials; Cardiac tissue models; Disease modeling; Drug screening; In vitro cardiac tissue engineering; Regenerative medicine; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 26428618      PMCID: PMC4832980          DOI: 10.1016/j.addr.2015.09.011

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  107 in total

1.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.

Authors:  W H Zimmermann; C Fink; D Kralisch; U Remmers; J Weil; T Eschenhagen
Journal:  Biotechnol Bioeng       Date:  2000-04-05       Impact factor: 4.530

2.  Novel cell lines derived from adult human ventricular cardiomyocytes.

Authors:  Mercy M Davidson; Claudia Nesti; Lluis Palenzuela; Winsome F Walker; Evelyn Hernandez; Lev Protas; Michio Hirano; Nithila D Isaac
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

3.  An on-chip cardiomyocyte cell network assay for stable drug screening regarding community effect of cell network size.

Authors:  Tomoyuki Kaneko; Kensuke Kojima; Kenji Yasuda
Journal:  Analyst       Date:  2007-06-27       Impact factor: 4.616

Review 4.  Substrates for cardiovascular tissue engineering.

Authors:  C V C Bouten; P Y W Dankers; A Driessen-Mol; S Pedron; A M A Brizard; F P T Baaijens
Journal:  Adv Drug Deliv Rev       Date:  2011-01-25       Impact factor: 15.470

5.  Microfluidic patterning for fabrication of contractile cardiac organoids.

Authors:  Ali Khademhosseini; George Eng; Judy Yeh; Peter A Kucharczyk; Robert Langer; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Biomed Microdevices       Date:  2007-04       Impact factor: 2.838

Review 6.  On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.

Authors:  Yue Shao; Jianming Sang; Jianping Fu
Journal:  Biomaterials       Date:  2015-02-21       Impact factor: 12.479

7.  Three-dimensional paper-based model for cardiac ischemia.

Authors:  Bobak Mosadegh; Borna E Dabiri; Matthew R Lockett; Ratmir Derda; Patrick Campbell; Kevin Kit Parker; George M Whitesides
Journal:  Adv Healthc Mater       Date:  2014-02-12       Impact factor: 9.933

Review 8.  Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Claire Robertson; David D Tran; Steven C George
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

9.  Human iPSC-based cardiac microphysiological system for drug screening applications.

Authors:  Anurag Mathur; Peter Loskill; Kaifeng Shao; Nathaniel Huebsch; SoonGweon Hong; Sivan G Marcus; Natalie Marks; Mohammad Mandegar; Bruce R Conklin; Luke P Lee; Kevin E Healy
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

10.  High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias.

Authors:  Emanuel J P Nazareth; Joel E E Ostblom; Petra B Lücker; Shreya Shukla; Manuel M Alvarez; Steve K W Oh; Ting Yin; Peter W Zandstra
Journal:  Nat Methods       Date:  2013-10-20       Impact factor: 28.547

View more
  42 in total

1.  Engineering a naturally-derived adhesive and conductive cardiopatch.

Authors:  Brian W Walker; Roberto Portillo Lara; Chu Hsiang Yu; Ehsan Shirzaei Sani; William Kimball; Shannon Joyce; Nasim Annabi
Journal:  Biomaterials       Date:  2019-03-21       Impact factor: 12.479

Review 2.  Three-dimensional scaffold-free microtissues engineered for cardiac repair.

Authors:  Alejandra Patino-Guerrero; Jaimeson Veldhuizen; Wuqiang Zhu; Raymond Q Migrino; Mehdi Nikkhah
Journal:  J Mater Chem B       Date:  2020-07-29       Impact factor: 6.331

Review 3.  In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish.

Authors:  Celinda M Kofron; Ulrike Mende
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

Review 4.  Cardiovascular Organ-on-a-Chip Platforms for Drug Discovery and Development.

Authors:  João Ribas; Hossein Sadeghi; Amir Manbachi; Jeroen Leijten; Katelyn Brinegar; Yu Shrike Zhang; Lino Ferreira; Ali Khademhosseini
Journal:  Appl In Vitro Toxicol       Date:  2016-06-01

Review 5.  3D bioprinting for cardiovascular regeneration and pharmacology.

Authors:  Haitao Cui; Shida Miao; Timothy Esworthy; Xuan Zhou; Se-Jun Lee; Chengyu Liu; Zu-Xi Yu; John P Fisher; Muhammad Mohiuddin; Lijie Grace Zhang
Journal:  Adv Drug Deliv Rev       Date:  2018-07-24       Impact factor: 15.470

Review 6.  Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

Authors:  Houman Savoji; Mohammad Hossein Mohammadi; Naimeh Rafatian; Masood Khaksar Toroghi; Erika Yan Wang; Yimu Zhao; Anastasia Korolj; Samad Ahadian; Milica Radisic
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

7.  Electromechanical Stimulation of 3D Cardiac Microtissues in a Heart-on-Chip Model.

Authors:  Roberta Visone; Paola Occhetta; Marco Rasponi
Journal:  Methods Mol Biol       Date:  2022

Review 8.  Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment.

Authors:  Alison Schroer; Gaspard Pardon; Erica Castillo; Cheavar Blair; Beth Pruitt
Journal:  Prog Biophys Mol Biol       Date:  2018-12-20       Impact factor: 4.799

Review 9.  Extracellular matrix-based biomaterials for cardiac regeneration and repair.

Authors:  Haotong Li; Minghui Bao; Yu Nie
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

10.  Maladaptive Contractility of 3D Human Cardiac Microtissues to Mechanical Nonuniformity.

Authors:  Chenyan Wang; Sangmo Koo; Minok Park; Zacharias Vangelatos; Plansky Hoang; Bruce R Conklin; Costas P Grigoropoulos; Kevin E Healy; Zhen Ma
Journal:  Adv Healthc Mater       Date:  2020-02-23       Impact factor: 11.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.